Page 63 - Read Online
P. 63

Page 8 of 11             Riachi et al. Mini-invasive Surg 2023;7:14  https://dx.doi.org/10.20517/2574-1225.2022.120

               CONCLUSIONS
               In conclusion, through the development of more efficient and advanced technology, RPD continues to
               surmount the technical challenges that previously limited the progression of minimally invasive pancreatic
               surgery. Active prospective randomized control trials will help elucidate the relationship between RPD and
               surgical outcomes. Continued development and implementation of educational curricula for residency and
               fellowship training programs is critical to the expansion and improvement of robotic surgery. Finally,
               advancements in AI offer innovative solutions to reduce errors and improve outcomes.

               DECLARATIONS
               Authors’ contributions
               Design, literature research and review, critical review of the manuscript, final approval: Riachi ME, Hewitt
               DB
               Drafted the manuscript: Riachi ME

               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest


               Ethical approval and consent to participate
               Not applicable.


               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2023.


               REFERENCES
               1.       Puckett Y, Garfield K. Pancreatic cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.  PubMed
               2.       Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022;72:7-33.  DOI  PubMed
               3.       Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the
                   unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.  DOI  PubMed
               4.       Brown ZJ, Cloyd JM. Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma. J Surg Oncol
                   2021;123:1432-40.  DOI  PubMed
               5.       Halsted WS. Contributions to the surgery of the bile passages, especially of the common bile-duct. Boston Med Surg J 1899;141:645-
                   54.  DOI
               6.       Whipple AO. Observations on radical surgery for lesions of the pancreas. Surg Gynecol Obstet 1946;82:623-31.  PubMed
               7.       Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006;244:10-5.  DOI
                   PubMed  PMC
               8.       Cameron JL, He J. Two thousand consecutive pancreaticoduodenectomies. J Am Coll Surg 2015;220:530-6.  DOI  PubMed
               9.       Simon R. Complications after pancreaticoduodenectomy. Surg Clin North Am 2021;101:865-74.  DOI  PubMed
               10.      Kang CM, Lee JH. Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol 2015;21:5794-804.  DOI  PubMed  PMC
               11.      Gagner M, Pomp A. Laparoscopic pylorus-preserving pancreatoduodenectomy. Surg Endosc 1994;8:408-10.  DOI  PubMed
               12.      Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg
                   2003;138:777-84.  DOI
               13.      Robinson TN, Stiegmann GV. Minimally invasive surgery. Endoscopy 2004;36:48-51.  DOI
   58   59   60   61   62   63   64   65   66   67   68